| P50 | author | Balapal S Basavarajappa | Q44392579 |
| P2093 | author name string | Shivakumar Subbanna | |
| P2860 | cites work | Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity | Q21135310 |
| | Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats | Q24630223 |
| | Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding | Q28143431 |
| | Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats | Q28272826 |
| | Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus | Q28275230 |
| | Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 |
| | Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects | Q28472191 |
| | Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 |
| | International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 |
| | Synaptic plasticity and memory: an evaluation of the hypothesis | Q29619840 |
| | CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory | Q30392902 |
| | Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. | Q30493991 |
| | Long-term effects of cannabis on brain structure. | Q33923622 |
| | Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists | Q33983584 |
| | JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist | Q34098234 |
| | Spice drugs as a new trend: mode of action, identification and legislation | Q34121927 |
| | Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors | Q34212305 |
| | Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line | Q34215210 |
| | Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB1 receptors and glutamatergic transmission | Q47595024 |
| | Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. | Q48020201 |
| | Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. | Q48028956 |
| | Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange | Q48198217 |
| | Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study. | Q48257078 |
| | Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ9 -tetrahydrocannabinol. | Q48269342 |
| | Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats | Q48279511 |
| | Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies | Q48301733 |
| | Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. | Q48569237 |
| | Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. | Q48658239 |
| | Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice | Q48970084 |
| | Functional effects of synthetic cannabinoids versus Δ9 -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression | Q50052091 |
| | ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BKCa channels, and nitric oxide dependent mechanisms. | Q50057295 |
| | The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis | Q50151709 |
| | AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice | Q34223229 |
| | 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice | Q34236794 |
| | Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. | Q34325190 |
| | The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse | Q34336690 |
| | Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order | Q34408874 |
| | CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression | Q34412161 |
| | Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists | Q34453695 |
| | Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice | Q34581274 |
| | Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 |
| | Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search | Q34607414 |
| | Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications | Q34617484 |
| | Long lasting consequences of cannabis exposure in adolescence | Q34764034 |
| | JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys | Q35650744 |
| | Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market | Q35836423 |
| | Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions | Q35887816 |
| | Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice | Q36409544 |
| | Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine | Q36508621 |
| | Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs | Q36573225 |
| | Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors | Q36938493 |
| | Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus | Q37029175 |
| | Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles | Q37397048 |
| | Diuretic effects of cannabinoid agonists in mice | Q37413414 |
| | A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors | Q37578979 |
| | CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations | Q37648995 |
| | Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. | Q38431693 |
| | Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice. | Q38616780 |
| | MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors | Q38902712 |
| | Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8. | Q39009725 |
| | Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy | Q39121700 |
| | The central neuropharmacology of psychotropic cannabinoids | Q39632100 |
| | Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence. | Q39653751 |
| | Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus | Q40216225 |
| | The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. | Q40290354 |
| | JWH-018 impairs sensorimotor functions in mice. | Q40926033 |
| | Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice | Q41227667 |
| | AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice | Q42366580 |
| | Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone. | Q50542166 |
| | Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. | Q52301471 |
| | The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. | Q52537508 |
| | Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. | Q52651312 |
| | Repeated Exposure to the "Spice" Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats. | Q52657192 |
| | Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats. | Q53094148 |
| | Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons | Q56966579 |
| | A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats | Q57461950 |
| | Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THC | Q57491573 |
| | Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ-THC in Rats | Q58573307 |
| | Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats | Q59797649 |
| | Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. | Q64904627 |
| | The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor | Q73091531 |
| | Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes | Q77341707 |
| | The synthetic cannabinoid 5F-AMB changes the balance between excitation and inhibition of layer V pyramidal neurons in the mouse medial prefrontal cortex | Q88955716 |
| | Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2 | Q90015321 |
| | Synthetic cannabinoid, JWH-030, induces QT prolongation through hERG channel inhibition | Q90844573 |
| | Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice | Q93015114 |
| | Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids | Q93138753 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoids | Q422936 |
| | CNRs [plasma membrane] | Q50272675 |
| P304 | page(s) | 14 | |
| P577 | publication date | 2019-01-16 | |
| P1433 | published in | Brain Sciences | Q27724596 |
| P1476 | title | Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice/K2 Products | |
| P478 | volume | 9 | |